A time-dependent explainable radiomic analysis from the multi-omic cohort of CPTAC-Pancreatic Ductal Adenocarcinoma
View abstract on PubMed
Summary
This summary is machine-generated.Radiomics improves prognostic models for Pancreatic Ductal Adenocarcinoma (PDA). Survival machine-learning classifiers integrated with radiomics enhance patient risk stratification and provide explainable predictions for overall survival and recurrence.
Area Of Science
- Oncology
- Bioinformatics
- Medical Imaging
Background
- Pancreatic Ductal Adenocarcinoma (PDA) presents unmet clinical needs for novel prognostic factors.
- Multi-omic models are emerging to address these needs.
- This study leverages public multi-omic datasets from the CPTAC-PDA project.
Purpose Of The Study
- To develop and validate a pipeline using survival machine-learning (SML) classifiers and explainability methods.
- To stratify prognosis in PDA patients using multi-omic data.
- To identify quantitative prognostic factors for overall survival (OS) and recurrence (REC).
Main Methods
- Analysis of radiologic images, clinical, and mutational data.
- Feature selection using univariate (UV) and multivariate (MV) survival analyses.
- Comparison of four SML classifiers (Cox, survival random forest, generalized boosted, SVM) with concordance (C) index assessment.
- Explainability analysis using SurvSHAP(t) for top-performing models.
Main Results
- SML classifiers incorporating radiomics outperformed those using only clinical or mutational data.
- For OS, a Cox model with radiomic, clinical, and mutational features achieved a 75% C index.
- For REC, an SVM model with radiomics achieved a 68% C index.
- Key predictors included radiomic features (e.g., Median Gray Level intensities), gender, and tumor grade.
Conclusions
- Radiomics demonstrates significant potential for improving risk stratification in PDA.
- The study provides a time-dependent explainability of top multi-omic predictors in PDA prognosis.
- This approach enhances the understanding of radiomics' contribution to predicting patient outcomes.

